This year, Science for health will plot the course for the Belgian life sciences ecosystem towards a bright future in gene therapy, based on expert insights into the field’s unique challenges and inspiring stories of success.
At this yearly event, experts are connected around a central theme to promote out-of-the-box thinking and spark new research collaborations. This strengthens the local ecosystem and creates inspired solutions improving the life of patients.
Meet academics, industry leaders and policymakers — Get inspired and join forces!
Programme
- 10:00 – 10:15 Welcome by MEDVIA
- 10:15 – 10:45 Gene therapy: current and future treatment modalities, Katherine High, AskBio
- 10:45 – 11:10 Clinical development and regulatory challenges, Willeke van Roon, DCRT
- 11:10 – 12:10 Panel discussion on health economics, patient perspectives and pricing
- 12:10 – 12:35 Challenges in manufacturing, Morgan O’Brien, Janssen Pharmaceutica
- 12:35 – 13:45 Lunch and networking exhibition
Parallel session: Gene Restauration
- 13:45 – 14:10 In-vivo dendritic cell transfection to treat cancer – eTheRNA, speaker TBC
- 14:10 – 14:35 Gene therapies for neurological disorders – Monica Bennett, Novartis
Parallel session: Gene Controlling and Silencing
- 13:45 – 14:10 ASO therapies in oncology – Rob MacLeod, Flamingo Therapeutics
- 14:10 – 14:35 Pharmacological control of therapeutic transgene expression – Sebastian Kügler, University of Göttingen
Plenary session: how to build a bright future for gene therapy in Belgium?
- 15:05 – 15:30 How can governments help? An overview of selected European cases | Filip De Weerdt, Flanders Investment and Trade
- 15:30 – 16:15 Panel discussion: the future of Belgian gene therapy
- 16:15 – 16:45 How to overcome the technical challences we all face? | Federico Mingozzi, Spark Therapeutics
- 16:45 – 17:55 Closing remarks
- 17:55 – 19:00 Networking reception
Science for health is a joint organization from the following partners:
